880230 | 18:1 PEG5000 PE
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt)

18:1 PEG5000 PE
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt)
Representative Structure
The molecular weight and exact mass are averages based on the polydispersity of PEG.
C269H535N2O123P (average FW due to polydispersity of PEG)
C 55.73%, H 9.30%, N 0.48%, O 33.95% P 0.53%
CAS Registry Number is a Registered Trademark of the American Chemical Society
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
- Safety Data Sheet
- Certificate of Analysis (Lot No. 880230C-200MG-A-033 and 6309CNA033)
- Certificate of Analysis (Lot No. 880230C-25MG-A-033 and 6309CJA033)
- Certificate of Analysis (Lot No. 880230P-200MG-A-033 and 6309PNA033)
- Certificate of Analysis (Lot No. 880230P-25MG-A-033 and 6309PJA033)
- Certificate of Analysis (Lot No. 880230C-25MG-A-034 and 6309CJA034)
- Certificate of Analysis (Lot No. 880230P-200MG-A-034 and 6309PNA034)
- Certificate of Analysis (Lot No. 880230C-25MG-A-034 and 6309CJA034)
- Certificate of Analysis (Lot No. 880230C-CONF-A-034 and 6309CWA034)
- Certificate of Analysis (Lot No. 880230P-200MG-B-034 and 6309PNB034)
- Certificate of Analysis (Lot No. 880230C-25MG-B-034 and 6309CJB034)
- Certificate of Analysis (Lot No. 880230P-200MG-C-034 and 6309PNC034)
- Certificate of Analysis (Lot No. 880230P-200MG-D-034 and 6309PND034)
- Certificate of Analysis (Lot No. 880230C-25MG-C-034 and 6309CJC034)
- Certificate of Analysis (Lot No. 880230C-5MG-A-034 and 6309CHA034)
- Certificate of Analysis (Lot No. 880230P-200MG-E-034 and 6309PNE034)
- Certificate of Analysis (Lot No. 880230P-25MG-B-034 and 6309PJB034)
- Certificate of Analysis (Lot No. 880230C-CONF-B-034 and 6309CWB034)
- Certificate of Analysis (Lot No. 880230P-25MG-C-034 and 6309PJC034)
- Certificate of Analysis (Lot No. 880230C-25MG-D-034 and 6309CJD034)
- Certificate of Analysis (Lot No. 880230C-25MG-E-034 and 6309CJE034)
- Certificate of Analysis (Lot No. 880230C-25MG-F-034 and 6309CJF034)
- Certificate of Analysis (Lot No. 880230C-25MG-G-034 and 6309CJG034)
- Certificate of Analysis (Lot No. 880230P-200MG-F-034 and 6309PNF034)
- Certificate of Analysis (Lot No. 880230P-25MG-D-034 and 6309PJD034)
- Certificate of Analysis (Lot No. 880230P-200MG-H-034 and 6309PNH034)
- Certificate of Analysis (Lot No. 880230P-25MG-E-034 and 6309PJE034)
- Certificate of Analysis (Lot No. 880230P-200MG-I-034 and 6309PNI034)
- Certificate of Analysis (Lot No. 880230C-25MG-A-035 and 6309CJA035)
- Certificate of Analysis (Lot No. 880230P-200MG-A-035 and 6309PNA035)
Xu X, Hou B, Fulzele A, Masubuchi T, Zhao Y, Wu Z, Hu Y, Jiang Y, Ma Y, Wang H, Bennett EJ, Fu G, Hui E. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. J Cell Biol. 2020 Jun 1;219(6):e201905085. doi: 10.1083/jcb.201905085. PMID: 32437509; PMCID: PMC7265324.
PubMed ID: 32437509Pan J, Attia SA, Subhan MA, Filipczak N, Mendes LP, Li X, Kishan Yalamarty SS, Torchilin VP. Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA. Mol Pharm. 2020 May 4;17(5):1638-1647. doi: 10.1021/acs.molpharmaceut.0c00075. Epub 2020 Apr 10. PMID: 32233497.
PubMed ID: 32233497Das S, Lazenby RA, Yuan Z, White RJ, Park YC. Effect of Laser Irradiation on Reversibility and Drug Release of Light-Activatable Drug-Encapsulated Liposomes. Langmuir. 2020 Apr 7;36(13):3573-3582. doi: 10.1021/acs.langmuir.0c00215. Epub 2020 Mar 27. PMID: 32188250.
PubMed ID: 32188250Sasmal DK, Feng W, Roy S, Leung P, He Y, Cai C, Cao G, Lian H, Qin J, Hui E, Schreiber H, Adams EJ, Huang J. TCR-pMHC bond conformation controls TCR ligand discrimination. Cell Mol Immunol. 2019 Sep 17. doi: 10.1038/s41423-019-0273-6. [Epub ahead of print]
PubMed ID: 31530899Ditlev JA, Vega AR, Köster DV, Su X, Tani T, Lakoduk AM, Vale RD, Mayor S, Jaqaman K, Rosen MK. A composition-dependent molecular clutch between T cell signaling condensates and actin. Elife. 2019 Jul 3;8. pii: e42695. doi: 10.7554/eLife.42695.
PubMed ID: 31268421Pan J, Mendes LP, Yao M, Filipczak N, Garai S, Thakur GA, Sarisozen C, Torchilin VP. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance. Eur J Pharm Biopharm. 2019 Mar;136:18-28. doi: 10.1016/j.ejpb.2019.01.006. Epub 2019 Jan 8.
PubMed ID: 30633973Pan J, Mendes LP, Yao M, Filipczak N, Garai S, Thakur GA, Sarisozen C, Torchilin VP. Polyamidoamine dendrimers-based nanomedicine for combination therapy with siRNA and chemotherapeutics to overcome multidrug resistance. Eur J Pharm Biopharm. 2019 Mar;136:18-28. doi: 10.1016/j.ejpb.2019.01.006. Epub 2019 Jan 8.
PubMed ID: 30633973